Stockchase Opinions

Robert McWhirter Algernon Pharmaceuticals Inc. AGN-X HOLD May 29, 2020

It produces a drug that has been repurposed for anti-anxiety in Japan. When you look at COVID-19 and its related illnesses, the drug can be used to help with chronic cough and pneumonia. Their chronic cough trial is going into Phase II in Australia. He owns it personally.
N/A

Stock price when the opinion was issued

Pharma & Healthcare
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.